Summary & Overview
HCPCS M1210: At Least Two High-Risk Medication Orders Not Ordered
HCPCS Level II code M1210 denotes the absence of at least two orders for high-risk medications from the same drug class as specified in clinical guidance (table 4). Nationally, the code is used to document instances where recommended or expected ordering of high-risk medications did not occur, important for medication safety monitoring, quality measurement, and clinical documentation standards.
Key payers in analyses typically include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical meaning, the common settings where it applies, and the implications for billing and medical record documentation. The publication outlines benchmarks and reporting contexts where M1210 may appear, relevant policy considerations affecting coding and quality programs, and clinical context around medication reconciliation and high-risk drug classes.
The report does not provide clinical recommendations. It focuses on operational clarity: how the code is defined, where it is typically applied, which payers commonly encounter it, and what types of documentation support its use. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code M1210 documents when at least two orders for high-risk medications from the same drug class (table 4) were not ordered. The code captures a lapse in ordering recommended high-risk medications within the same therapeutic class and is used to record that these orders were not placed.
Service type: Medication management / high-risk medication ordering review
Typical site of service: Inpatient or outpatient clinical settings where medication orders are reviewed and reconciled, including hospitals, skilled nursing facilities, and ambulatory clinics.
Clinical & Coding Specifications
Clinical Context
A 78-year-old female resident of a long-term care facility is seen by a primary care clinician for medication regimen review after a hospitalization for urinary tract infection. The facility’s pharmacist flags the medication list showing two orders for benzodiazepines (temazepam and lorazepam) for insomnia and intermittent agitation. The clinician reviews the chart, notes risks for falls and cognitive impairment, and documents a decision that the two orders from the same high-risk drug class will not be continued. The clinician records the rationale, discontinues the duplicate class orders in the medication administration record, communicates the change to the nursing staff, and updates the problem list and transfer/discharge paperwork.
Typical workflow steps:
-
Medication reconciliation and pharmacy review identify multiple orders from the same high-risk class.
-
Clinician assesses risks, documents clinical rationale for not ordering/reordering both agents, and updates orders.
-
Communication of the change to nursing/pharmacy and inclusion in the after-visit summary or transfer documentation.
-
Billing staff applies the HCPCS Level II code
M1210to indicate that at least two orders for high-risk medications from the same drug class were identified and not ordered, using appropriate modifiers as needed for the encounter.
Coding Specifications
| Modifier |
|---|